High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis

Peritoneal Dialysis International

Volumn 28, Issue 1, 2008, Pages 82-92

  Yang, Xiao ^a,b   Fang, Wei ^a   Bargman, Joanne M ^a   Oreopoulos, Dimitrios G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Patient survival; Peritoneal transport status; Technique failure

Indexed keywords

DIALYSIS FLUID; ICODEXTRIN; GLUCAN; GLUCOSE; HEMODIALYSIS FLUID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; ULTRAFILTRATION; CELL MEMBRANE PERMEABILITY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PERITONEUM; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CELL MEMBRANE PERMEABILITY; COHORT STUDIES; FEMALE; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 42449121530     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800114     Document Type: Article

References (39)

1. Selgas R, Bajo MA, Cirugeda A, del Peso G, Valdes J, Castro MJ, et al. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int 2005; 25:68-76.
2. Heaf J. Pathogenic effects of a high peritoneal transport rate. Semin Dial 2000; 13:188-93.
3. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9:1285-92.
4. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, et al. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000; 20:541-7.
5. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.
6. Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17:271-8.
7. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17:2591-8.
8. Passadakis PS, Thodis ED, Panagoutsos SA, Selisiou CA, Pitta EM, Vargemezis VA. Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high peritoneal transport status. Perit Dial Int 2001; 21(Suppl 3):S80-5.
9. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al.; Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-20.
10. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al.; EAPOS Group. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-57.
11. Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23:174-83.
12. Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 2006; 21: 763-9.
13. Fernandez Reyes MJ, Bajo MA, Hevia C, del Peso G, Ros S, de Miguel AG, et al. Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance. Nephrol Dial Transplant 2007; 22:218-23.
14. Churchill DN, Taylor DW, Keshaviah PR, for the CANUSA Penitoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
15. Baker IP, Detsky AS, Wesson DE. Nutritional assessment: a comparison of clinical judgment and objective measurements. N Engl J Med 1982; 306:969-72.
16. Twardowski ZJ, Nolph KD, Khanna R. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
17. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
18. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6:198-206.
19. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158-62.
20. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/ V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64:649-56.
21. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
22. Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis 2005; 45:891-902.
23. Nolph KD, Moore HL, Prowant B. Continuous peritoneal dialysis with a high flux membrane. ASAJO J 1993; 39: 904-9.
24. Churchill DN. Patient selection for automated peritoneal dialysis on the basis of peritoneal transport characteristics. Contrib Nephrol 1999; 129:69-74.
25. Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant 2005; 20: 1207-13.
26. Wu CH, Huang CC, Huang JY, Wu MS, Leu ML. High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Perit Dial 1996; 12:105-9.
27. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
28. Davies SJ, Brown EA, Reigel W, Clutterbuck E, Heimburger O, Diaz NV, et al.; EAPOS Group. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26:458-65.
29. Davies SJ. Exploring new evidence of the clinical benefits of icodextrin solutions. Nephrol Dial Transplant 2006; 21(Suppl 2):ii47-ii50.
30. Wolfson M, Piraino B, Hamburger RJ, Mortin AR; for the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
31. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.
32. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
33. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2:2.
34. Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil. A, et al.; EAPOS Group. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67:1609-15.
35. Heimburger O. Peritoneal transport with icodextrin solution. Contrib Nephrol 2006; 150:97-103.
36. Jeloka TK, Ersoy FF, Yavuz M, Sahu KM, Camsari T, Utah C, et al. What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int 2006; 26:336-40.
37. Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int Suppl 2006; 70:S76-83.
38. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004; 43:492-501.
39. Raj DS, Langos V, Gangam N, Roscoe J. Ethnic variability in peritoneal equilibration test and urea kinetics. Am J Kidney Dis 1997; 30:374-81.